Intact Investment Management Inc. Amgen Inc Transaction History

Intact Investment Management Inc.

$2.79 Billion
Q3 2024

A detailed history of Intact Investment Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Intact Investment Management Inc. holds 25,800 shares of AMGN stock, worth $6.8 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

25,800

Previous 25,300 1.98%

Holding current value

$6.8 Million

Previous $7.9 Million 5.17%

% of portfolio

0.3%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $154,690 - $168,690	500 Added 1.98%	25,800 $8.31 Million
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $4.91 Million - $5.97 Million	-18,700 Reduced 42.5%	25,300 $7.9 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $7.02 Million - $8.47 Million	26,100 Added 145.81%	44,000 $12.5 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $743,410 - $922,963	-3,400 Reduced 15.96%	17,900 $4.81 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.55 Million - $3.02 Million	-11,900 Reduced 35.84%	21,300 $4.73 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $519,317 - $632,960	-2,300 Reduced 6.48%	33,200 $8.03 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.31 Million - $1.66 Million	5,700 Added 19.13%	35,500 $9.32 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $2.21 Million - $2.46 Million	-9,600 Reduced 24.37%	29,800 $7.25 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $5.7 Million - $6.31 Million	-26,000 Reduced 39.76%	39,400 $9.52 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $6.4 Million - $7.33 Million	32,200 Added 96.99%	65,400 $14.7 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.15 Million - $1.34 Million	-5,200 Reduced 13.54%	33,200 $8.26 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $2.18 Million - $2.43 Million	-9,300 Reduced 19.5%	38,400 $9.75 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $613,211 - $752,494	-3,100 Reduced 6.1%	47,700 $11.2 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $4.65 Million - $6.16 Million	25,500 Added 100.79%	50,800 $10.3 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $4.79 Million - $6.15 Million	25,300 New	25,300 $6.1 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $5.37 Million - $6.91 Million	-28,400 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $3.48 Million - $4.17 Million	-20,000 Reduced 41.32%	28,400 $5.5 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $733,480 - $859,804	4,400 Added 10.0%	48,400 $8.92 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $1.21 Million - $1.37 Million	6,700 Added 17.96%	44,000 $8.36 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $741,160 - $835,560	-4,000 Reduced 9.69%	37,300 $7.73 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $680,805 - $764,691	-4,100 Reduced 9.03%	41,300 $7.62 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $7.42 Million - $8.67 Million	43,800 Added 2737.5%	45,400 $7.74 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $267,664 - $305,600	1,600	1,600 $298,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.

Account

Intact Investment Management Inc. Amgen Inc Transaction History